W
William Small
Researcher at Loyola University Chicago
Publications - 423
Citations - 15241
William Small is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 56, co-authored 396 publications receiving 12744 citations. Previous affiliations of William Small include University of Hong Kong & University of Chicago.
Papers
More filters
Journal ArticleDOI
Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society.
Surbhi Grover,Matthew M. Harkenrider,Linda P. Cho,Beth Erickson,Christina Small,William Small,Akila N. Viswanathan +6 more
TL;DR: Although use of image-based brachytherapy has increased in the United States since the 2007 survey, there is room for further growth, particularly with the use of MRI, and future efforts should be geared toward standardizing treatment.
Journal ArticleDOI
The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
Akila N. Viswanathan,Jennifer Moughan,William Small,Charles F Levenback,Revathy B. Iyer,Sharon R. Hymes,Adam P. Dicker,Brigitte Miller,Beth Erickson,David K. Gaffney +9 more
TL;DR: Assessment of the quality of a brachytherapy implant is imperative, as proper placement has an impact on patient DFS, and inappropriate placements should be corrected before treatment initiation.
Journal ArticleDOI
Colorectal Cancer Initial Diagnosis: Screening Colonoscopy, Diagnostic Colonoscopy, or Emergent Surgery, and Tumor Stage and Size at Initial Presentation.
Courtney C. Moreno,Pardeep Mittal,Patrick S. Sullivan,Robin E. Rutherford,Charles A. Staley,Kenneth Cardona,Natalyn Hawk,W. Thomas Dixon,Hiroumi D. Kitajima,Jian Kang,William Small,John N. Oshinski,John R. Votaw +12 more
TL;DR: Nearly 90% of colorectal cancer patients were diagnosed after development of symptoms and had more advanced disease than asymptomatic screening patients.
Journal ArticleDOI
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.
Tyvin A. Rich,Jonathan Harris,Ross A. Abrams,Beth Erickson,M. Doherty,J. Paradelo,William Small,Howard Safran,Harold J. Wanebo +8 more
TL;DR: External irradiation plus concurrent weekly paclitaxel and irradiation combined with a second radiation sensitizer, gemcitabine, is well tolerated when given with large-field radiotherapy and is the basis for a new Radiation Therapy Oncology Group trial, now under way.
Journal ArticleDOI
RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma
Tracey E. Schefter,Kathryn Winter,Janice S. Kwon,Kelly Stuhr,Khalid Balaraj,Brian Yaremko,William Small,William T. Sause,David K. Gaffney +8 more
TL;DR: In this study, bevacizumab in combination with standard pelvic chemoradiation therapy for locally advanced cervical cancer showed efficacy results that are promising and may warrant further investigation.